BX Swiss TOP 30 CHF
|
1 324,81
|
9,24
|
0,70 %
|
Analysen zu BX Swiss TOP 30 CHF-Werten
| 30.11.23 | ABB Buy | Goldman Sachs Group Inc. | |
| 30.11.23 | ABB Buy | UBS AG | |
| 30.11.23 | ABB Market-Perform | Bernstein Research | |
| 30.11.23 | Richemont Overweight | Barclays Capital | |
| 30.11.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.11.23 | Richemont Buy | Deutsche Bank AG | |
| 30.11.23 | Novartis Buy | Deutsche Bank AG | |
| 30.11.23 | ABB Outperform | RBC Capital Markets | |
| 29.11.23 | Novartis Underweight | Barclays Capital | |
| 29.11.23 | Richemont Sector Perform | RBC Capital Markets | |
| 29.11.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 29.11.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.11.23 | Swiss Re Hold | Deutsche Bank AG | |
| 29.11.23 | Zurich Insurance Hold | Deutsche Bank AG | |
| 28.11.23 | Nestlé Overweight | Barclays Capital | |
| 28.11.23 | ABB Outperform | RBC Capital Markets | |
| 28.11.23 | Novartis Neutral | UBS AG | |
| 28.11.23 | Novartis Buy | Jefferies & Company Inc. | |
| 28.11.23 | Givaudan Underperform | Bernstein Research | |
| 28.11.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 27.11.23 | Zurich Insurance Overweight | Barclays Capital | |
| 27.11.23 | Swiss Re Equal Weight | Barclays Capital | |
| 27.11.23 | Novartis Buy | Deutsche Bank AG | |
| 27.11.23 | Givaudan Hold | Deutsche Bank AG | |
| 24.11.23 | ABB Neutral | JP Morgan Chase & Co. | |
| 24.11.23 | UBS Outperform | RBC Capital Markets | |
| 24.11.23 | Richemont Overweight | Barclays Capital | |
| 22.11.23 | UBS Outperform | RBC Capital Markets |
HOT STOCKS DER LETZTEN 3 TAGE
| Novartis | 5 |
| ABB | 4 |
| Roche | 2 |
| Zurich Insurance | 1 |
| Richemont | 1 |